All stock lists
Krystal Biotech, Inc. (NASDAQ:KRYS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
311.50-8.63 (-2.70%)
Insider Score
––Not scored
KRYS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
KRYS analyst forecast
KRYS analyst consensus
No analyst ratings in the last 3 months.
KRYS 12-month price target
$441.00+41.0% upsideaverage of 1 firm
$441.00High
$441.00Low
Best analysts covering KRYS
No firm covering KRYS has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
KRYS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Goldman Sachs | — | $441.00 | +29.0% | — | 2026-09-24 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.